HEADER TRANSFERASE/INHIBITOR 20-MAR-20 6W8L TITLE CRYSTAL STRUCTURE OF JAK1 KINASE WITH COMPOUND 10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: JANUS KINASE 1,JAK-1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK1, JAK1A, JAK1B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 5 15-NOV-23 6W8L 1 REMARK REVDAT 4 18-OCT-23 6W8L 1 REMARK REVDAT 3 29-APR-20 6W8L 1 JRNL REVDAT 2 22-APR-20 6W8L 1 JRNL REVDAT 1 08-APR-20 6W8L 0 JRNL AUTH A.FENSOME,C.M.AMBLER,E.ARNOLD,M.E.BANKER,J.D.CLARK, JRNL AUTH 2 M.E.DOWTY,I.V.EFREMOV,A.FLICK,B.S.GERSTENBERGER,R.S.GIFFORD, JRNL AUTH 3 A.GOPALSAMY,M.HEGEN,J.JUSSIF,D.C.LIMBURG,T.H.LIN,B.S.PIERCE, JRNL AUTH 4 R.SHARMA,J.I.TRUJILLO,F.F.VAJDOS,F.VINCENT,Z.K.WAN,L.XING, JRNL AUTH 5 X.YANG,X.YANG JRNL TITL DESIGN AND OPTIMIZATION OF A SERIES OF JRNL TITL 2 4-(3-AZABICYCLO[3.1.0]HEXAN-3-YL)PYRIMIDIN-2-AMINES: DUAL JRNL TITL 3 INHIBITORS OF TYK2 AND JAK1. JRNL REF BIOORG.MED.CHEM. V. 28 15481 2020 JRNL REFN ESSN 1464-3391 JRNL PMID 32253095 JRNL DOI 10.1016/J.BMC.2020.115481 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 17475 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 885 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.24 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2795 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2100 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2627 REMARK 3 BIN R VALUE (WORKING SET) : 0.2095 REMARK 3 BIN FREE R VALUE : 0.2169 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 168 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2281 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.75390 REMARK 3 B22 (A**2) : 1.73630 REMARK 3 B33 (A**2) : -0.98240 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.221 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.173 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.224 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.175 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2384 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3239 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 852 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 411 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2384 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 291 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2644 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.17 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 10.4202 4.3892 -16.8440 REMARK 3 T TENSOR REMARK 3 T11: -0.1885 T22: -0.1487 REMARK 3 T33: -0.1834 T12: 0.0158 REMARK 3 T13: -0.0253 T23: 0.0206 REMARK 3 L TENSOR REMARK 3 L11: 2.1041 L22: 2.0610 REMARK 3 L33: 1.3519 L12: 0.2884 REMARK 3 L13: 0.3900 L23: 0.7541 REMARK 3 S TENSOR REMARK 3 S11: -0.0655 S12: 0.1757 S13: 0.2168 REMARK 3 S21: -0.0624 S22: -0.0133 S23: 0.0394 REMARK 3 S31: -0.0620 S32: 0.0772 S33: 0.0788 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6W8L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1000247825. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17476 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.110 REMARK 200 RESOLUTION RANGE LOW (A) : 73.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 1.01000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 6DBN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.5, 6-9% MPD, 24-29% REMARK 280 PEG-1500, PH 8.0, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.38000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.38000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 22.96000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.41500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 22.96000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.41500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 73.38000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 22.96000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.41500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 73.38000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 22.96000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 44.41500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 839 REMARK 465 SER A 840 REMARK 465 ILE A 841 REMARK 465 MET A 842 REMARK 465 ARG A 843 REMARK 465 ASP A 844 REMARK 465 ILE A 845 REMARK 465 ASN A 846 REMARK 465 LYS A 847 REMARK 465 LEU A 848 REMARK 465 GLU A 849 REMARK 465 GLU A 850 REMARK 465 GLN A 851 REMARK 465 ASN A 852 REMARK 465 PRO A 853 REMARK 465 ASP A 854 REMARK 465 ILE A 855 REMARK 465 VAL A 856 REMARK 465 SER A 857 REMARK 465 GLU A 858 REMARK 465 LYS A 859 REMARK 465 LYS A 860 REMARK 465 PRO A 861 REMARK 465 ALA A 862 REMARK 465 THR A 863 REMARK 465 GLU A 864 REMARK 465 VAL A 865 REMARK 465 ASP A 866 REMARK 465 PRO A 912 REMARK 465 GLU A 913 REMARK 465 SER A 914 REMARK 465 GLY A 915 REMARK 465 GLY A 916 REMARK 465 ASP A 947 REMARK 465 GLY A 948 REMARK 465 GLY A 949 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1029 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A1003 35.03 -146.58 REMARK 500 HIS A1096 138.10 74.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R4S A 1201 DBREF 6W8L A 841 1154 UNP P23458 JAK1_HUMAN 841 1154 SEQADV 6W8L GLY A 839 UNP P23458 EXPRESSION TAG SEQADV 6W8L SER A 840 UNP P23458 EXPRESSION TAG SEQRES 1 A 316 GLY SER ILE MET ARG ASP ILE ASN LYS LEU GLU GLU GLN SEQRES 2 A 316 ASN PRO ASP ILE VAL SER GLU LYS LYS PRO ALA THR GLU SEQRES 3 A 316 VAL ASP PRO THR HIS PHE GLU LYS ARG PHE LEU LYS ARG SEQRES 4 A 316 ILE ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS VAL GLU SEQRES 5 A 316 LEU CYS ARG TYR ASP PRO GLU GLY ASP ASN THR GLY GLU SEQRES 6 A 316 GLN VAL ALA VAL LYS SER LEU LYS PRO GLU SER GLY GLY SEQRES 7 A 316 ASN HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU ILE LEU SEQRES 8 A 316 ARG ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR LYS GLY SEQRES 9 A 316 ILE CYS THR GLU ASP GLY GLY ASN GLY ILE LYS LEU ILE SEQRES 10 A 316 MET GLU PHE LEU PRO SER GLY SER LEU LYS GLU TYR LEU SEQRES 11 A 316 PRO LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN GLN LEU SEQRES 12 A 316 LYS TYR ALA VAL GLN ILE CYS LYS GLY MET ASP TYR LEU SEQRES 13 A 316 GLY SER ARG GLN TYR VAL HIS ARG ASP LEU ALA ALA ARG SEQRES 14 A 316 ASN VAL LEU VAL GLU SER GLU HIS GLN VAL LYS ILE GLY SEQRES 15 A 316 ASP PHE GLY LEU THR LYS ALA ILE GLU THR ASP LYS GLU SEQRES 16 A 316 PTR PTR THR VAL LYS ASP ASP ARG ASP SER PRO VAL PHE SEQRES 17 A 316 TRP TYR ALA PRO GLU CYS LEU MET GLN SER LYS PHE TYR SEQRES 18 A 316 ILE ALA SER ASP VAL TRP SER PHE GLY VAL THR LEU HIS SEQRES 19 A 316 GLU LEU LEU THR TYR CYS ASP SER ASP SER SER PRO MET SEQRES 20 A 316 ALA LEU PHE LEU LYS MET ILE GLY PRO THR HIS GLY GLN SEQRES 21 A 316 MET THR VAL THR ARG LEU VAL ASN THR LEU LYS GLU GLY SEQRES 22 A 316 LYS ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP GLU VAL SEQRES 23 A 316 TYR GLN LEU MET ARG LYS CYS TRP GLU PHE GLN PRO SER SEQRES 24 A 316 ASN ARG THR SER PHE GLN ASN LEU ILE GLU GLY PHE GLU SEQRES 25 A 316 ALA LEU LEU LYS MODRES 6W8L PTR A 1034 TYR MODIFIED RESIDUE MODRES 6W8L PTR A 1035 TYR MODIFIED RESIDUE HET PTR A1034 16 HET PTR A1035 16 HET R4S A1201 50 HETNAM PTR O-PHOSPHOTYROSINE HETNAM R4S N-[(1S,5R)-3-(5-FLUORO-2-{[1-(2-HYDROXYETHYL)-1H- HETNAM 2 R4S PYRAZOL-4-YL]AMINO}PYRIMIDIN-4-YL)-3- HETNAM 3 R4S AZABICYCLO[3.1.0]HEXAN-1-YL]CYCLOPROPANECARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 R4S C18 H22 F N7 O2 FORMUL 3 HOH *31(H2 O) HELIX 1 AA1 GLU A 871 ARG A 873 5 3 HELIX 2 AA2 HIS A 918 ASN A 931 1 14 HELIX 3 AA3 SER A 963 LEU A 968 1 6 HELIX 4 AA4 PRO A 969 ASN A 971 5 3 HELIX 5 AA5 ASN A 976 ARG A 997 1 22 HELIX 6 AA6 ALA A 1005 ARG A 1007 5 3 HELIX 7 AA7 PRO A 1044 TYR A 1048 5 5 HELIX 8 AA8 ALA A 1049 SER A 1056 1 8 HELIX 9 AA9 ILE A 1060 THR A 1076 1 17 HELIX 10 AB1 ASP A 1079 SER A 1082 5 4 HELIX 11 AB2 SER A 1083 GLY A 1093 1 11 HELIX 12 AB3 MET A 1099 GLU A 1110 1 12 HELIX 13 AB4 PRO A 1121 CYS A 1131 1 11 HELIX 14 AB5 GLN A 1135 ARG A 1139 5 5 HELIX 15 AB6 SER A 1141 LEU A 1153 1 13 SHEET 1 AA1 5 LEU A 875 GLU A 883 0 SHEET 2 AA1 5 GLY A 887 TYR A 894 -1 O VAL A 889 N LEU A 881 SHEET 3 AA1 5 GLN A 904 LEU A 910 -1 O SER A 909 N LYS A 888 SHEET 4 AA1 5 ILE A 952 GLU A 957 -1 O LEU A 954 N LYS A 908 SHEET 5 AA1 5 TYR A 940 THR A 945 -1 N LYS A 941 O ILE A 955 SHEET 1 AA2 2 TYR A 999 VAL A1000 0 SHEET 2 AA2 2 LYS A1026 ALA A1027 -1 O LYS A1026 N VAL A1000 SHEET 1 AA3 2 VAL A1009 SER A1013 0 SHEET 2 AA3 2 GLN A1016 ILE A1019 -1 O LYS A1018 N LEU A1010 SHEET 1 AA4 2 PTR A1034 THR A1036 0 SHEET 2 AA4 2 LYS A1057 TYR A1059 -1 O PHE A1058 N PTR A1035 LINK C GLU A1033 N PTR A1034 1555 1555 1.33 LINK C PTR A1034 N PTR A1035 1555 1555 1.33 LINK C PTR A1035 N THR A1036 1555 1555 1.34 SITE 1 AC1 16 LEU A 881 GLY A 882 GLU A 883 GLY A 884 SITE 2 AC1 16 VAL A 889 ALA A 906 MET A 956 GLU A 957 SITE 3 AC1 16 PHE A 958 LEU A 959 PRO A 960 GLY A 962 SITE 4 AC1 16 SER A 963 GLU A 966 LEU A1010 ASP A1021 CRYST1 45.920 88.830 146.760 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021777 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006814 0.00000